Stock 2126 JW (CAYMAN) THERAPEUTICS CO. LTD
Add to a list
To use this feature you must be a member
Log inSign up

Insiders JW (Cayman) Therapeutics Co. Ltd

Equities

2126

KYG5210T1040

Delayed Hong Kong S.E.
Other stock markets
 02:49:27 2024-07-16 am EDT 		5-day change 1st Jan Change
1.78 HKD -3.78% Intraday chart for JW (Cayman) Therapeutics Co. Ltd -4.81% -21.24%
May. 30 JW (Cayman) Therapeutics Presents Trial Data from SLE Drug at Rheumatology Congress MT
May. 30 JW Therapeutics Co. Ltd Announces Research and Development Update Preliminary Clinical Data on Relma-Cel Injection in Adults with Active Systemic Lupus Erythematosus in China At the EURAL 2024 Congress CI

Insiders

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
JW Therapeutics CFO Resigns
MT
JW Therapeutics Co. Ltd Announces Board Changes
CI
JW Therapeutics Co. Ltd Appoints Debra Yu as Independent Non-Executive Director and Member of Remuneration Committee and Nomination Committee
CI
JW Therapeutics Co. Ltd Announces Resignation of Chi Shing Li as Independent Non-Executive Director and the Chairman of the Remuneration Committee of the Board and Nomination Committee of the Board, Effective January 1, 2023
CI
JW Therapeutics Appoints Immunotherapy Expert as Chief Scientific Officer
MT
JW Therapeutics Announces Management Appointments
CI
JW Therapeutics Co. Ltd Announces Executive Changes
CI
JW Therapeutics Co. Ltd Announces Board and Committee Changes
CI
JW Therapeutics Co. Ltd. Announces Change of Company Secretary
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 2126 Stock
  4. News JW (Cayman) Therapeutics Co. Ltd
  5. Insiders